Stereotaxis, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on March 6, 2018, reporting events occurring on February 28, 2018, and March 5, 2018. The filing primarily addresses a definitive material agreement regarding the amendment of outstanding warrants and references financial results for the fourth quarter and full year ended December 31, 2017.
Key Financial Metrics and Capital Structure
The filing details a significant capital raise through warrant exercises rather than reporting standard operating metrics directly in the text.
- Warrant Exercise Proceeds: The Company received an aggregate exercise price of $10,021,739.
- Shares Issued: Upon settlement, the Company will issue 35,791,927 shares of common stock.
- Exercise Price: Warrants were exercised at a reduced price of $0.28 per share (down from $0.70).
- Operating Results: Specific revenue, profit, cash flow, and margin figures for the fiscal year 2017 are not provided in this filing text; they are incorporated by reference in an attached press release (Exhibit 99.1).
Material Changes and Agreements
On February 28, 2018, the Company entered into a Consent and Amendment with holders of the majority of outstanding SPA Warrants. Key changes include:
- Price Reduction: The exercise price was reduced to $0.28 per share for a restricted period from March 1 to March 5, 2018.
- Conditions Met: The exercise condition requiring a minimum aggregate exercise price of $6,000,000 was satisfied.
- Lock-Up Agreement: Exercising holders agreed to an 18-month lock-up period on the shares received, commencing March 12, 2018.
- Waivers: The amendment waived registration defaults and obligations for registration delay payments under the 2016 Registration Rights Agreement, contingent on the filing of a new registration statement within 30 days.
Outlook, Risks, and Contingencies
The filing includes standard forward-looking statement disclaimers, noting that future performance is subject to risks and uncertainties. The Company does not intend to update these statements except as required by law. A specific contingency noted is the requirement to file a new registration statement (or post-effective amendment) to register the resale of the newly issued shares within 30 days of the amendment, with effectiveness required within 60 days thereafter.
Investor Verification Checklist
- Verify the effectiveness of the new registration statement for the 35,791,927 newly issued shares.
- Review the attached Earnings Press Release (Exhibit 99.1) for specific Q4 and full-year 2017 revenue and cash flow figures.
- Confirm the 18-month lock-up expiration date for the new shares (March 12, 2019).
- Assess the dilution impact of issuing approximately 35.8 million shares at $0.28 per share.